SILENCE THER. (SLN)

 

SLN Share PerformanceMore

52 week high133.75 03/06/16
52 week low80.47 26/04/17
52 week change -46.00 (-35.66%)
4 week volume395,378 31/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Additional Listing

RNS Number: 3542C Silence Therapeutics PLC 12 April 2017 Additional listing 12 April 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has issued and allotted 190,000 new ordinary share...

Grant of Share Options to Directors

RNS Number: 2721B Silence Therapeutics PLC 03 April 2017 Grant of share options to Directors 3 April 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that it has granted share options ("Optio...

Preliminary Results for the year to 31 Dec 2016

RNS Number: 6802A Silence Therapeutics PLC 28 March 2017 Preliminary results for the year to 31 December 2016 28 March 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces its preliminary r...

Notice of Results

RNS Number: 8042Y Silence Therapeutics PLC 08 March 2017 Notice of Results 8 March 2017 London, 8 March 2017 - Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, plans to announce its Preliminary Result...

Silence update on stake in Arrowhead Pharmaceuticals

Silence Therapeutics has issued an update to its announcement on 9 January regarding the acquisition of a minority stake ...

Minority Stake in Arrowhead Pharmaceuticals

RNS Number: 1602U Silence Therapeutics PLC 13 January 2017 Minority stake in Arrowhead Pharmaceuticals 13 th January 2017 London, 13 th January 2017 - Silence Therapeutics plc, AIM:SLN ("Silence" or the "Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, p...

Silence Therapeutics acquires minority stake in Arrowhead

Silence Therapeutics has acquired a stake, on-market, in Arrowhead Pharmaceuticals, Inc. of 6.01m shares, or 8.4% of the co...

Acquisition of Minority Stake in Arrowhead

RNS Number: 6001T Silence Therapeutics PLC 09 January 2017 Acquisition of minority stake in Arrowhead Pharmaceuticals 9 th January 2017 London, 9 th January 2017 - Silence Therapeutics plc, AIM:SLN ("Silence" or the "Company") a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet m...

Fundamental DataMore

EPS-12.1
Dividend yield0 %

Equity Research (SLN)

edison investment research
Silence Therapeutics plc
13/04/2017
Edison Investment Research is terminating coverage on Silence Therapeutics (SLN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should...

Latest discussion posts More

Users' HoldingsMore

Users who hold SILENCE THER. also hold..
LLOYDS GRP.28%
BP23%
TESCO19%
ROYAL BANK SCOT17%
BARCLAYS17%

Codes & Symbols

ISINGB00B9GTXM62
SymbolsSLN, LSE:SLN, SLN.L, SLN:LN, LON:SLN, XLON:SLN